NLM Logo

reslizumab MeSH Supplementary Concept Data 2022


MeSH Supplementary
reslizumab
Unique ID
C515492
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C515492
Entry Term(s)
CEP-38072
CEP38072
Cinqair
DCP 835
DCP-835
DCP835
SCH 55700
SCH-55700
SCH55700
Pharm Action
Anti-Asthmatic Agents
Registry Number
35A26E427H
Previous Indexing
*ANTIBODIES, MONOCLONAL (2006-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
135
Note
Humanized anti-IL-5 monoclonal antibody used for treatment in patients with nasal polyps. It is also used in the treatment of ASTHMA.
Source
J Allergy Clin Immunol 2006 Nov;118(5):1133-41
Indexing Information
Interleukin-5
Date of Entry
2006/12/14
Revision Date
2019/11/01
reslizumab Preferred
SCH-55700 Narrower
CEP-38072 Narrower
Cinqair Narrower
DCP-835 Narrower
page delivered in 0.004s